IP Library Granted Patent US 11,839,699
Granted Patent B2
US 11,839,699 · App. 16/632,992 · Granted Dec 12, 2023

3D printed scaffolds of peptide conjugate polymer

Inventors: Lesley W. Chow (Bethlehem, PA); Hannah L. Dailey (Neshanic Station, NJ); Hafiz Busari (Greenville, SC); Peter Schwarzenberg (Fountain Hill, PA); Katherine Hudson (Hopkinton, MA)
A61L27/54A61L27/18A61L27/58B29C64/106B33Y10/00B33Y70/00B33Y80/00A61L2430/02A61L2430/06A61L2430/10A61L2430/24B29K2067/00B29K2089/00B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,839,699
App. No.
16/632,992
Granted
Dec 12, 2023
Kind
B2
Abstract

Described herein is a 3D-printed scaffold comprising a peptide-polymer conjugate, the peptide-polymer conjugate having the structure: X-Y-Z-Y-X, wherein X is a biologically active peptide, Y is a linker moiety, and Z is a biocompatible and biodegradable polymer.

Claims (22)

1. A 3D-printed scaffold comprising a peptide-polymer conjugate, the peptide-polymer conjugate having the structure:

X-Y-Z-Y-X

wherein X is a biologically active peptide; Y is a linker moiety comprising a maleimide functionalized compound and at least one of a hydroxyl-reactive group, an aromatic group, or an aliphatic chain; and Z is a biocompatible polymer.

2. The 3D-printed scaffold of claim 1 , wherein Z is poly(caprolactone).

3. The 3D-printed scaffold of claim 2 , wherein the poly(caprolactone) has a molecular weight ranging from about 10,000 to about 18,000 g/mol.

4. The 3D-printed scaffold according to claim 1 , further comprising a high molecular weight polymer blended with the peptide-polymer conjugate.

5. The 3D-printed scaffold according to claim 4 , wherein the high molecular weight polymer comprises poly(caprolactone) homopolymer.

6. The 3D-printed scaffold according to claim 1 , wherein the maleimide functionalized compound comprises an isocyanate group.

7. The 3D-printed scaffold according to claim 1 , wherein Y is formed from p-maleimidophenyl isocyanate.

8. The 3D-printed scaffold according to claim 1 , wherein the biologically active peptide is formed with a thiol-functionalized peptide.

9. The 3D-printed scaffold according to claim 8 , wherein the thiol-functionalized peptide is a cysteine containing peptide.

10. The 3D-printed scaffold according to claim 1 , wherein the biologically active peptide comprises about 5 to about 30 amino acids.

11. An implantable scaffold comprising:

a first layer comprising a plurality of first fibers oriented in a first direction, wherein the plurality of first fibers have a diameter ranging from about 40 μm to about 200 μm; and

a second layer comprising a plurality of second fibers oriented in a second direction wherein the plurality of second fibers have a diameter ranging from about 40 μm to about 200 μm;

wherein the first direction and the second direction are different and the diameter of the first plurality of fibers is smaller than the diameter of the second plurality of fibers, and wherein the pluralities of first and second fibers comprise peptide-polymer conjugate.

12. The implantable scaffold according to claim 11 , wherein the peptide-polymer conjugate comprises poly(caprolactone) block and terminal peptide blocks.

13. The implantable scaffold according to claim 11 , wherein each of the plurality of first fibers have substantially the same diameter.

14. The implantable scaffold according to claim 11 , wherein each of the plurality of second fibers have substantially the same diameter.

15. The implantable scaffold according to claim 11 , wherein the first direction intersects the second direction to form an intersection angle, whereby the intersection angle is a right angle, or an oblique angle.

16. The implantable scaffold according to claim 11 , further comprising a third layer formed of a plurality of third fibers oriented in a third direction, wherein the third direction is not parallel to the first direction or the second direction.

17. The implantable scaffold according to claim 16 , wherein the implantable scaffold comprising at least fourteen layers, each comprising a corresponding plurality of fibers.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2020
From: CHOW, LESLEY W.; DAILEY, HANNAH L.; BUSARI, HAFIZ; SCHWARZENBERG, PETER; HUDSON, KATHERINE
To: LEHIGH UNIVERSITY
Reel/Frame 053097/0183 →
Continuity (2)
Provisional Application 62535955 · Jul 23, 2017
Related Publication 20200206384A1 · Jul 2, 2020
Cited By (1)
US 12,370,290